The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Aerovate Therapeutics, Inc. | COMM | 008064107 | 44,315 | 3,758,686 | SH | SOLE | 3,758,686 | 0 | 0 | ||
Akouos, Inc. | COMM | 00973J101 | 12,878 | 1,515,074 | SH | SOLE | 1,515,074 | 0 | 0 | ||
Ascendis Pharma A/S | ADR | 04351P101 | 67,241 | 499,824 | SH | SOLE | 499,824 | 0 | 0 | ||
Bolt Biotherapeutics, Inc. | COMM | 097702104 | 13,497 | 2,754,437 | SH | SOLE | 2,754,437 | 0 | 0 | ||
Checkmate Pharmaceuticals Inc | COMM | 162818108 | 10,351 | 3,606,707 | SH | SOLE | 3,606,707 | 0 | 0 | ||
Fusion Pharmaceuticals Inc | COMM | 36118A100 | 326 | 78,066 | SH | SOLE | 78,066 | 0 | 0 | ||
Galera Therapeutics, Inc | COMM | 36338D108 | 14,154 | 3,083,712 | SH | SOLE | 3,083,712 | 0 | 0 | ||
Inozyme Pharma, Inc. | COMM | 45790W108 | 13,833 | 2,028,308 | SH | SOLE | 2,028,308 | 0 | 0 | ||
Karuna Therapeutics, Inc. | COMM | 48576A100 | 255,770 | 1,952,441 | SH | SOLE | 1,952,441 | 0 | 0 | ||
Natera Inc | COMM | 632307104 | 289,561 | 3,100,560 | SH | SOLE | 3,100,560 | 0 | 0 | ||
Nextcure, Inc | COMM | 65343E108 | 16,031 | 2,671,856 | SH | SOLE | 2,671,856 | 0 | 0 | ||
Nucana Plc | ADR | 67022C106 | 13,328 | 5,599,999 | SH | SOLE | 5,599,999 | 0 | 0 | ||
Nucana Plc | Ordinary Shares | GB00BYWYV | 5,712 | 2,400,000 | SH | SOLE | 2,400,000 | 0 | 0 | ||
ObsEva SA | COMM | H5861P103 | 9,452 | 4,749,623 | SH | SOLE | 4,749,623 | 0 | 0 | ||
PDS Biotechnology Corporation | COMM | 70465T107 | 1,155 | 142,635 | SH | SOLE | 142,635 | 0 | 0 | ||
Synlogic Inc. | COMM | 87166L100 | 1,391 | 574,972 | SH | SOLE | 574,972 | 0 | 0 | ||
Vera Therapeutics, Inc. | CL A | 92337R101 | 77,883 | 2,914,776 | SH | SOLE | 2,914,776 | 0 | 0 | ||
Y-mAbs Therapeutics, Inc | COMM | 984241109 | 35,569 | 2,194,278 | SH | SOLE | 2,194,278 | 0 | 0 | ||
Abbvie Inc | COMM | 00287Y109 | 42,247 | 312,018 | SH | SOLE | 312,018 | 0 | 0 | ||
Adicet Bio Inc | COMM | 007002108 | 5,439 | 310,988 | SH | SOLE | 310,988 | 0 | 0 | ||
Agenus Inc | COMM | 00847G705 | 6,315 | 1,961,032 | SH | SOLE | 1,961,032 | 0 | 0 | ||
Align Technology Inc | COMM | 016255101 | 25,077 | 38,159 | SH | SOLE | 38,159 | 0 | 0 | ||
Aligos Therapeutics Inc | COMM | 01626L105 | 1,517 | 127,791 | SH | SOLE | 127,791 | 0 | 0 | ||
Axsome Therapeutics Inc | COMM | 05464T104 | 3,778 | 100,000 | SH | Put | SOLE | 100,000 | 0 | 0 | |
BioCryst Pharmaceuticals Inc | COMM | 09058V103 | 20,920 | 1,510,473 | SH | SOLE | 1,510,473 | 0 | 0 | ||
Biomarin Pharmaceutical Inc | COMM | 09061G101 | 7,715 | 87,322 | SH | SOLE | 87,322 | 0 | 0 | ||
Blueprint Medicines Corp | COMM | 09627Y109 | 26,261 | 245,182 | SH | SOLE | 245,182 | 0 | 0 | ||
Celldex Therapeutics Inc | COMM | 15117B202 | 10,492 | 271,533 | SH | SOLE | 271,533 | 0 | 0 | ||
ChemoCentryx Inc | COMM | 16383L106 | 26,624 | 731,222 | SH | SOLE | 731,222 | 0 | 0 | ||
Cyteir Therapeutics Inc | COMM | 23284P103 | 2,040 | 179,450 | SH | SOLE | 179,450 | 0 | 0 | ||
Cytokinetics Inc | COMM | 23282W605 | 21,166 | 464,366 | SH | SOLE | 464,366 | 0 | 0 | ||
Dexcom Inc | COMM | 252131107 | 17,399 | 32,404 | SH | SOLE | 32,404 | 0 | 0 | ||
Edwards Lifesciences Corp | COMM | 28176E108 | 182 | 1,406 | SH | SOLE | 1,406 | 0 | 0 | ||
Fulcrum Therapeutics Inc | COMM | 359616109 | 10,927 | 617,670 | SH | SOLE | 617,670 | 0 | 0 | ||
Guardant Health Inc | COMM | 40131M109 | 23,261 | 232,563 | SH | SOLE | 232,563 | 0 | 0 | ||
Heron Therapeutics Inc | COMM | 427746102 | 26,781 | 2,933,351 | SH | SOLE | 2,933,351 | 0 | 0 | ||
Horizon Therapeutics PLC | COMM | G46188101 | 23,900 | 221,792 | SH | SOLE | 221,792 | 0 | 0 | ||
Immatics NV | COMM | N44445109 | 13,798 | 1,026,623 | SH | SOLE | 1,026,623 | 0 | 0 | ||
ImmunoGen Inc | COMM | 45253H101 | 12,984 | 1,749,882 | SH | SOLE | 1,749,882 | 0 | 0 | ||
Inflarx NV | COMM | N44821101 | 5,530 | 1,161,736 | SH | SOLE | 1,161,736 | 0 | 0 | ||
Inhibrx Inc | COMM | 45720L107 | 16,100 | 368,679 | SH | SOLE | 368,679 | 0 | 0 | ||
Insmed Inc | COMM | 457669307 | 12,034 | 441,773 | SH | SOLE | 441,773 | 0 | 0 | ||
Insulet Corp | COMM | 45784P101 | 284 | 1,066 | SH | SOLE | 1,066 | 0 | 0 | ||
Intercept Pharmaceuticals Inc | COMM | 45845P108 | 2,450 | 150,400 | SH | Call | SOLE | 150,400 | 0 | 0 | |
Intra-Cellular Therapies Inc | COMM | 46116X101 | 2,979 | 56,915 | SH | SOLE | 56,915 | 0 | 0 | ||
Invesco QQQ Trust Series 1 | COMM | 46090E103 | 39,785 | 100,000 | SH | Put | SOLE | 100,000 | 0 | 0 | |
Iveric Bio Inc | COMM | 46583P102 | 13,356 | 798,789 | SH | SOLE | 798,789 | 0 | 0 | ||
Jounce Therapeutics Inc | COMM | 481116101 | 13,216 | 1,582,777 | SH | SOLE | 1,582,777 | 0 | 0 | ||
Karuna Therapeutics Inc | COMM | 48576A100 | 83 | 636 | SH | SOLE | 636 | 0 | 0 | ||
Kura Oncology Inc | COMM | 50127T109 | 5,168 | 369,173 | SH | SOLE | 369,173 | 0 | 0 | ||
Kura Oncology Inc | COMM | 50127T109 | 2,450 | 175,000 | SH | Call | SOLE | 175,000 | 0 | 0 | |
Marinus Pharmaceuticals Inc | COMM | 56854Q200 | 2,035 | 171,338 | SH | SOLE | 171,338 | 0 | 0 | ||
Mink Therapeutics Inc | COMM | 603693102 | 1,541 | 345,499 | SH | SOLE | 345,499 | 0 | 0 | ||
Natera Inc | COMM | 632307104 | 224 | 2,400 | SH | SOLE | 2,400 | 0 | 0 | ||
Novocure Ltd | COMM | G6674U108 | 3,754 | 50,000 | SH | Call | SOLE | 50,000 | 0 | 0 | |
PTC Therapeutics Inc | COMM | 69366J200 | 5,275 | 132,448 | SH | SOLE | 132,448 | 0 | 0 | ||
Protagonist Therapeutics Inc | COMM | 74366E102 | 10,281 | 300,600 | SH | Call | SOLE | 300,600 | 0 | 0 | |
Protagonist Therapeutics Inc | COMM | 74366E102 | 16,493 | 482,257 | SH | SOLE | 482,257 | 0 | 0 | ||
Regenxbio Inc | COMM | 75901B107 | 32,964 | 1,008,081 | SH | SOLE | 1,008,081 | 0 | 0 | ||
Roche Holding AG | ADR | 771195104 | 70,764 | 1,369,011 | SH | SOLE | 1,369,011 | 0 | 0 | ||
SPDR S&P 500 ETF Trust | COMM | 78462F103 | 47,496 | 100,000 | SH | Put | SOLE | 100,000 | 0 | 0 | |
Sarepta Therapeutics Inc | COMM | 803607100 | 10,872 | 120,732 | SH | SOLE | 120,732 | 0 | 0 | ||
Sierra Oncology Inc | COMM | 82640U404 | 4,615 | 212,281 | SH | SOLE | 212,281 | 0 | 0 | ||
Syndax Pharmaceuticals Inc | COMM | 87164F105 | 20,822 | 951,226 | SH | SOLE | 951,226 | 0 | 0 | ||
Travere Therapeutics Inc | COMM | 89422G107 | 32,308 | 1,040,858 | SH | SOLE | 1,040,858 | 0 | 0 | ||
Uniqure NV | COMM | N90064101 | 10,267 | 495,025 | SH | SOLE | 495,025 | 0 | 0 | ||
United Therapeutics Corp | COMM | 91307C102 | 28,037 | 129,754 | SH | SOLE | 129,754 | 0 | 0 | ||
Vir Biotechnology Inc | COMM | 92764N102 | 8,374 | 200,000 | SH | Put | SOLE | 200,000 | 0 | 0 | |
Xencor Inc | COMM | 98401F105 | 21,546 | 537,030 | SH | SOLE | 537,030 | 0 | 0 | ||
Zymeworks Inc | COMM | 98985W102 | 6,437 | 392,712 | SH | SOLE | 392,712 | 0 | 0 | ||
iRhythm Technologies Inc | COMM | 450056106 | 19,876 | 168,882 | SH | SOLE | 168,882 | 0 | 0 | ||
iShares Russell 2000 ETF | COMM | 464287655 | 33,368 | 150,000 | SH | Put | SOLE | 150,000 | 0 | 0 |